PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system
Atherosclerosis is a primary precursor of cardiovascular disease (CVD), the leading cause of death worldwide. While proprotein convertase subtilisin/kexin 9 (PCSK9) contributes to CVD by degrading low-density lipoprotein receptors (LDLR) and altering lipid metabolism, PCSK9 also influences vascular...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2023-12-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/5.0167440 |